safranal has been researched along with Osteoporosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, ZH; He, GL; Jin, C; Jin, SQ; Sheng, SR; Tian, NF; Wu, YH; Xie, CL; Zhao, BY; Zheng, G; Zhou, X | 1 |
1 other study(ies) available for safranal and Osteoporosis
| Article | Year |
|---|---|
Safranal inhibits estrogen-deficiency osteoporosis by targeting Sirt1 to interfere with NF-κB acetylation.
Topics: Acetylation; Animals; Bone Resorption; Estrogens; Female; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoclasts; Osteoporosis; Ovariectomy | 2023 |